L19IL2/TNF in Patients With Basal Cell Carcinoma
NCT07227870
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced Basal Cell Carcinoma
Interventions
DRUG:
L19IL2/L19TNF
Sponsor
Philogen S.p.A.